News

By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. That's far too many. Imaging Endpoints is helping in the fight with imaging studies…   Read More

Celebrating healthcare heroes. Society places a great deal of emphasis on recognizing the celebrities that entertain us. Today we would like to recognize and express our deep gratitude for all the incredibly talented research scientists that develop new healthcare technologies,…   Read More

The U.S. Patent and Trademark Office has issued a patent to Imaging Endpoints and Chief Medical Officer Ron Korn for a new breakthrough radiomic evaluation tool which provides a biomarker for predicting tumor aggressiveness in breast cancer patients. It gives…   Read More

New imaging biomarker for predicting tumor aggressiveness. Scottsdale, Arizona – Imaging Endpoints announced today that the U.S. Patent and Trademark Office has issued Patent No. 10,854,338 – “PREDICTING BREAST CANCER RESPONSIVENESS TO HORMONE TREATMENT USING QUANTITATIVE TEXTURAL ANALYSIS” to Imaging…   Read More

Imaging Endpoints is a dynamic organization that’s widely considered the leading imaging CRO (iCRO) within oncology and complex clinical trials. We work passionately toward our mission to Connect Imaging to the CureTM for the benefit of all humanity. Since its…   Read More